Ad Scientiam develops software medical applications for patient monitoring in real life, collecting real-world data through digital tests, used to improve patient care and research
Founded in 2013, Ad Scientiam (ADS) is a company specialized in mHealth (mobile health) and real world medical data analysis, incubated at the Brain & Spine Institute (la Pitié-Salpêtrière Hospital, Paris). ADS is developing clinically-validated software medical applications, each specific to a chronic disease, where patients assess the evolution of their disease, in their home environment, taking regular tests on their:
- MSCopilot (“MSC”)is the first Solution launched by ADS.It is the result of 2.5 years of R&D in partnership with ROCHE France. MSC received its Class 1 CE mark (October 2017) and is distributed in France, since November 2017.
- ADS has a pipeline of 7 solutions(rheumatoid arthritis, depression, Parkinson’s…). The experience built from MSC will allow ADS to accelerate its development and distribution cycle and support its extension to the U.S.
ADS will develop its activities in Europe and in the U.S.In 2018, ADS wants to occupy a leading position on Multiple Sclerosis assessment with MSCopilot